Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METAZYM in Late Infantile MLD Post-HCT
NCT01303146Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2008
- Primary completion
- Mar 2010
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of cebsulfase alfa in metachromatic leukodystrophy (MLD), sponsored by Assistance publique - Hôpitaux de Paris. Started Oct 2008; status: completed.
02
Drugs
cebsulfase alfa
03
Conditions
metachromatic leukodystrophy (MLD)
Beyond the preview
Go deeper on NCT01303146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01303146.